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Abstract 
The chemical constituents and biological activities of Corydalis crispa (Fumariaceae) were investigated 
for the first time. The phytochemical study resulted in the isolation of nine known isoquinoline alkaloids: 
protopine (1), 13-oxoprotopine (2), 13-oxocryptopine (3), stylopine (4), coreximine (5), rheagenine (6), 
ochrobirine (7), sibiricine (8) and bicuculline (9), with complete NMR data for 2 and 3 provided here for the 
first time. Crude extracts exhibitedsignificant anti-inflammatory (p < 0.01) activity against TNF-alpha 
production in LPS activated THP-1 cells. The acetylcholinesterase inhibitory activity of compounds 2, 4 
and 7 and the antiplasmodial activity of compound 5 against P. falciparum strains TM4/8.2 and K1CB1 
(multidrug resistant strain) are reported here for the first time. Stylopine (4) did not show antimalarial 
activity against the K1CB1 strain in contrast to a previous report. This study generated a scientific basis 
for the use of this plant in Bhutanese traditional medicine, either individually or in combination with other 
medicinal ingredients to treat a broad range of disorders. This study also identified compound 5 as 
potential new antimalarial lead compound. 
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The chemical constituents and biological activities of Corydalis crispa (Fumariaceae) were investigated for the first time. The phytochemical study resulted in 
the isolation of nine known isoquinoline alkaloids: protopine (1), 13-oxoprotopine (2), 13-oxocryptopine (3), stylopine (4), coreximine (5), rheagenine (6), 
ochrobirine (7), sibiricine (8) and bicuculline (9), with complete NMR data for 2 and 3 provided here for the first time. Crude extracts exhibited significant 
anti-inflammatory (p<0.01) activity against TNF-α production in LPS activated THP-1 cells. The acetylcholinesterase inhibitory activity of compounds 2, 4 
and 7 and the antiplasmodial activity of compound 5 against P. falciparum strains TM4/8.2 and K1CB1 (multidrug resistant strain) are reported here for the 
first time. Stylopine (4) did not show antimalarial activity against the K1CB1 strain in contrast to a previous report. This study generated a scientific basis for 
the use of this plant in Bhutanese traditional medicine, either individually or in combination with other medicinal ingredients to treat a broad range of 
disorders. This study also identified compound 5 as potential new antimalarial lead compound.  
 




The genus Corydalis (Fumariaceae) are a rich source of 
isoquinoline alkaloids which mediate chemical defence against a 
variety of micro-organisms and herbivores [1-2]. While few plant 
species of this genus were reported for cattle and sheep poisoning 
[1], many species are regarded as non-toxic and are being used in 
Asian folklore medicines for treating different types of ailments [3-
4]. Owing to these interesting inherent properties, the Corydalis 
genus has been extensively studied. More than 58 Corydalis species 
have been studied phytochemically with over 190 isoquinoline 
alkaloids reported [5].  
 
However, no phytochemical and biological activity studies on the 
Bhutanese medicinal plant, C. crispa have been reported. Locally, it 
is known as ngo-ba-sha-ka in Bhutan and contributes to the 
preparation of as many as 21 important multi-ingredient Essential 
Traditional Medicine Drugs (ETMDs) or polyherbal formulations 
[6]. As an individual plant, C. crispa is used in the Bhutanese 
traditional medicine (BTM) as a febrifuge and for treating 
infections in the blood, liver and bile which correlate to the signs 
and symptoms of parasitic and microbial infections, tumor and 
inflammatory conditions [7]. We previously reported the 
antiplasmodial, antimicrobial, anti-Trypanosoma brucei rhodesiense 
and cytotoxicity activities of the crude extracts of this plant [7]. In 
this study, since this plant is also ethnopharmacologically indicated 
for the management of various inflammatory conditions in Bhutan, 
we first assessed the anti-inflammatory potential of its crude 
extracts and then investigated the phytochemical components of this 
plant followed by bioassays on the major compounds with a view to 
derive potential new drug lead compounds and generate scientific 
evidence for its ethnopharmacological uses.  
 
 
Figure 1: The structures of compounds 1-9. 
 
The phytochemical study of this plant resulted in the isolation of 
nine known isoquinoline alkaloids (Figure 1): protopine (1), 13-
oxoprotopine (2), 13-oxocryptopine (3), stylopine (4), coreximine 
(5), rheagenine (6), ochrobirine (7), sibiricine (8) and bicuculline 
(9).  
 
Compounds 1-4 belonged to the class of protopine alkaloids; 
compound 5 to the class of protoberberine alkaloids; compound 6 to 
the class of rhoeadine alkaloids; compounds 7 and 8 to the class of 
spirobenzylisoquinoline alkaloids; and compound 9 to the class of 
phthalide-isoquinoline alkaloids. The presence of more than one 
class of these alkaloids from a genus or even within a species has 
been reported [8]. Compound 6 has been reported previously from 
the genus of Papaver, Meconopsis, Glaucum, Roemeria, Bocconia 
and Fumaria [9-10]. However, this is the first rhoeadine-type 
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alkaloid being isolated from the genus Corydalis (Fumariaceae). Its 
presence in C. crispa is not that surprising since: a) rhoeadine 
alkaloids have been reported from its close relative Fumaria 
parviflora belonging to the same family of Fumariaceae; and b) 
rhoeadine alkaloids are the biogenetic derivatives of protopine [10]. 
Furthermore, direct evidence for the incorporation of labeled 
protopine into rhoeadine in P. rhoeas has been documented [11]. 
The literature on compounds 2 and 3, lacked full NMR 
characterisation and we have presented here for the first time (Table 
1). 
 
13-Oxoprotopine (2) was previously characterized only by melting 
point, UV, IR and MS data [12]. Compound 2 was isolated here as a 
white amorphous solid. Its melting point, molecular formula and the 
major ion fragmentation pattern corresponded with the reported data 
for 13-oxoprotopine [12-13]. The 1H-NMR spectrum of 2 showed 
the aromatic (CH) protons resonating at δ 7.43 (1H, s), 6.69 (1H, s), 
6.83 (1H, d, J = 8 Hz), and 7.46 (1H, br s). The gHSQC showed 
these protons linked to the carbon signals resonating at δ 109.1 (C-
1), 109.6 (C-4), 107.4 (C-11) and 125.9 (C-12), respectively. 
 




2 (in CDCl3) 3 (in CDCl3) 
δ C  δ H (mult., J (Hz) δ C δ H (mult., J (Hz) 
1 109.1 7.43 s 111.8 7.48 s 
2 145.1  147.0 
3 148.6  150.6 
4 109.6 6.69 s 112.4 6.70 s 
4a  131.9*  130.7 
5 29.14 1.26 br s 29.2 1.64 br s 
6 46.12* 2.65 br s 46.0* 2.64 br s 
8 50.06 3.64 br s 50.1 3.67 br s 
8a 120.0*  120.0 
9 146.0*  145.2 
10  147.0*  149.9 
11 107.4 6.83 d (8) 107.4 6.83 d (8) 
12 125.9 7.46 br s 125.9 7.49 br s 
12a 128.0*  128.1 
13, C=O 182.1*  182.0 * 
14, C=O 191.7  191.9 
14a 131.5  131.0* 
N-CH3 42.36 1.92 s 42.1 1.86 s 
2-OCH3 –  56.0 3.89 s  
3-OCH3 –  55.9 3.94 s 
2,3-OCH2O 101.3 5.99 s – – 
9,10-OCH2O 101.9 6.05 s 101.9 6.04 s 
* Signal only observed in the gHMBC spectrum. 
 
The two methylenedioxy protons were observed at δ 5.99 (2H, s) 
and 6.05 (2H, s) with its connected carbons resonating at δ 101.3 
and 101.9, respectively. The methylene (3×CH2) protons attached to 
C-atoms of C-5, C-6 and C-8 resonated as very broad peaks in the 
region of δ 1.26-3.64. The N-methyl protons resonated at δ 1.92 
(3H, s). The C-13 and C-14 carbonyl groups resonated at δ 182.1 
and δ 191.7, respectively. The gHMBC defined the final structure 2. 
To further confirm the structure 2, it was synthesized by oxidation 
of compound 1 with mercuric acetate and the compound 
synthesized was found identical to 13-oxoprotopine (2) by TLC, 
MS and 1H-NMR analysis. 
 
13-Oxocryptopine (3) was reported only from the family 
papaveraceae (P. somniferum) [9, 12] and this is the first report 
from the genus Corydalis (Fumariaceae). It was previously 
identified based on its melting point, MS and 1H-NMR data [12,14] 
and its 13C-NMR data has been lacking. Here, this compound 3 was 
obtained as an optically inactive pale green solid. The molecular 
formula, ion fragmentation pattern and the 1H-NMR data were 
consistent with those reported for 13-oxocryptopine (3) [12, 14]. 
The APT spectra indicated the presence of three methyl groups, 
four methylene, four methine and ten quaternary carbons. From the 
gHSQC spectrum the four aromatic protons (CH) correlated to C-1, 
C-4, C-11 and C-12 carbons whose signals resonated at δ 111.8, 
112.4, 107.4, and 125.9, respectively. A signal at δ 42.1 was 
assigned to the N-methyl carbon and the signals at δ 55.9 and 56.0 
were assigned to the two methoxy carbons. The carbon of the 
methylenedioxy group resonated at δ 101.9. The long range 
gHMBC correlation established the structure 3. 
 
The other known compounds were identified through MS library 
matching techniques (NIST08s) and then confirmed through 
comparison of their melting point, optical rotation, mass and NMR 
spectra with those reported in the relevant literature. Compound 1 
(950 mg) was identified as protopine [15-17], compound 4 (5 mg) 
as stylopine [15, 18-20], compound 5 (1 mg) as coreximine [21], 
compound 6 (1 mg) as rheagenine [10], compound 7 (60.6 mg) as 
ochrobirine [22-25], compound 8 (0.8 mg) as sibiricine [8, 23] and 
compound 9 as bicuculline [26-27]. 
 
In this study, prior to the investigation of its phytochemical contents 
and the biological activities of the major alkaloids, we first assessed 
the anti-inflammatory potential of its crude extracts against pro-
inflammatory cytokine, tumor necrosis factor-α (TNF-α) in LPS 
activated THP-1 cells. The uncontrolled production of this pro-
inflammatory cytokine by the immune system in response to 
infection, stimulates the over production of reactive oxygen species 
(ROS) which have been implicated in the pathogenesis of many 
forms of disease [28]. Thus, the pro-inflammatory cytokine (TNF-
α) in LPS activated THP-1 cells are commonly used for evaluating 
the anti-inflammatory effects of various materials.  
 
The anti-inflammatory assay (Table 2) demonstrated the level of 
TNF-α secretion of THP-1 monocytic cells and the percentage of 
TNF-α inhibition when incubated with crude extracts and pure 
alkaloids of the plant in the presence of LPS. The cytotoxic effects 
of the crude extracts and pure alkaloids on THP-1 cells were 
determined first on test samples at different concentrations. This 
cell viability test compositely indicated that, at 50 µg/mL of crude 
extracts and 3.9 µg/mL of pure alkaloids, there were no significant 
cell reduction. The percentage of viable cells in each sample was 
>90%. The percentage cell viability of RPMI was 97%, DMSO was 
98% and dexamethasone was 97%. This suggested that the 
inhibition of TNF-α production by the test samples were not 
associated with their cytotoxic effects to the THP-1 cells. The THP-
1 cells in RPMI and THP-1 cells incubated with the crude plant 
extracts or pure alkaloids alone (without LPS) did not activate TNF-
α production at the above mentioned non-cytotoxic concentrations. 
In the presence of each of the plant extracts and individual 
alkaloids, the TNF-α production was either suppressed or stimulated 
in varying degrees as compared to the secretion levels of TNF-α 
production of RPMI culture media control and the DMSO solvent 
control (Table 2).  
 
Among the four different solvent extracts, the hexane and 
dichloromethane extract showed significant anti-inflammatory 
activity with the suppression of TNF-α production to the values of 
142 pg/ml (77% inhibition) and 71 pg/ml (89% inhibition), 
respectively (Figure 2). The suppression of TNF-α production of 
these two crude extracts were much higher than the DMSO control 
and the positive control drug dexamethasone (Table 2). The 
chloroform extract also showed suppression of TNF-α production to 
the value of 284 pg/mL (54% inhibition). A Student’s t-test with 
one-tailed distribution showed that the results from the hexane and 
dichloromethane extracts (p<0.01) and the chloroform extract 
(p<0.05) were statistically significant (Figure 2). These significant 
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activities suggested that these crude extracts possess compounds 





























Controls and test samples (crude extracts)
 
Figure 2: Anti-inflammatory effects of crude extracts on TNF-α production in 
LPS-activated THP-1 monocytic cells. RPMI as cell culture media control; 
DMSO as solvent control; Dexamethasone as positive control drug; asterisks 
denote statistical significance in relative to solvent control; *(p<0.05); 
**(p<0.01); error bars indicate standard deviations. 
 
Guided by the potent biological activities of its crude extracts, out 
of nine isolated compounds, we investigated six major compounds 
1, 2, 4, 5, 7 and 9 for their anti-inflammatory, antiplasmodial, 
antimicrobial, anti-acetylcholinesterase, anti-Trypanosoma brucei 
rhodesiense and cytotoxicity activities (Table 2 and Table 3). 
Compound 1 exhibited significant anti-inflammatory, anti-
acetylcholinesterase and the antiplasmodial activities against 
Plasmodium falciparum strains: TM4/8.2 (a wild type chloroquine 
and antifolate sensitive strain) and K1CB1 (multidrug resistant 
strain) (Table 2). It also showed broad range of mild level 
antimicrobial activity against different bacterial strains as compared 
to other test compounds (Table 3). The antiplasmodial, 
antimicrobial, and anti-inflammatory activities of this compound 
were found in line with the previously reported data [15, 29-32]. 
Compounds 2 and 4 displayed stimulated effects on TNF-α 
production and moderately inhibited acetylcholinesterase. Kaya et 
al. [33] reported that compound 4 (stylopine) had significant 
antimalarial activity against the drug resistant P. falciparum K1 
strain with IC50 values of 0.23 μg/mL. However, we found that 
compound 4 was inactive even at the highest concentration of 4–4.6 
μg/mL. Indeed, previous studies indicated that compound 4 was 
inactive against P. berghei and P. falciparum [15, 34-35]. 
Compound 5 showed significant antiplasmodial activity against 
TM4/8.2 and K1CB1 strains with IC50 values of 5.56 ± 0.63 μg/mL 
and 6.87 ± 1.09 μg/mL, respectively. Thus, it has the potential to be 
a new candidate for antimalarial drug lead. This compound also 
moderately inhibited acetylcholinesterase (Table 2) and inhibited 
Helicobacter pylori and Bacillus subtilis with the MIZ of 6 and 5 
mm, respectively (Table 3). This MIZ values were significant when 
compared to that of the positive control, amoxicillin which inhibited 
the same strain with a MIZ value of 7 and 10 mm. However, they 
both showed only weak MIC values of 125 µg/mL.  In fact, all the 
alkaloids tested here showed weak antibacterial activity against H. 
pylori with MIC values of 125 µg/mL. Compound 7 showed weak 
anti-inflammatory and moderate anti-acetylcholinesterase activities. 
 
The anti-inflammatory, antimicrobial, antiplasmodial, anti-
Trypanosoma brucei rhodesiense and the cytotoxicity activities of 
the crude extracts were very interesting for the fact that this plant is 
being used in the Bhutanese traditional medicine (BTM) as a 
febrifuge and for treating infections in the blood, liver and bile 
which correlate to the signs and symptoms of parasitic and 
microbial infections, tumor and inflammatory conditions [7]. 
 
Table 2: Bioactivities of the crude extracts and the pure compounds 1, 2, 4, 5, 7, and 9 isolated from C. crispa. 
 
a Acetylcholinesterase inhibitory activity. b Anti-Trypanosoma brucei rhodesiense activity. Nt: Not tested; +: activated; −: inhibited. 
c Reference drug for anti-inflammatory activity.d Reference drug for acetylcholinesterase activity. e Reference drugs for antiplasmodial activity. 
f Positive control for anti-Trypanosoma brucei rhodesiense activity. g Positive controls for cytotoxicity activity.        
Table 3: Antimicrobial activities of the crude extracts and the pure compounds of C. crispa (Minimum Inhibition Zone (MIZ) in mm, well diameter = 4 mm; 
Minimum Inhibitory Concentration (MIC) in µg/mL). 
 
Samples 
Bacterial and fungal strains 
 V. cholerae     S. aureus     MRSA        E. coli     B. subtilis      S. epidermidis   H. pylori     C. albicans    












IC50 ( μg/mL) 
K1CB1 




IC50 ( μg/mL) 
KB cells 
IC50 ( μg/mL) 
MeOH extract 778 ±3 + (25) Nt 11.53 ±4.83 13.24 ±0.59 >10 >25 >25 
Hexane extract 142 ±17 − (77) Nt 14.57 ±1.76 15.82 ±3.94 >10 >25 >25 
CH2Cl2 extract   71 ±17 − (89) Nt 12.09 ±0.58 11.27 ±3.14 >25 >25 >25 
CHCl3 extract 284 ±10 − (54) Nt 2.11 ±0.55 1.89 ±0.20 4.63 ±0.53 >25 12.50 
1 467 ±4 − (25) 0.14 1.45±0.53 1.38±0.31 >3.5 >3.5 >3.5 
2 862 ±14 + (39) 1.31 >4.6 >4.6 >3.7 >3.7 >3.7 
4 679 ±28 + (10) 0.15 >4.0 >4.0. >3.2 >3.2 >3.2 
5 632 ±4 + (1) 0.53 5.56±0.63 6.87±1.09 >8.2 >8.2 >8.2 
7 606 ±30 − (2) 0.14 >9.2 >9.2 >9.2 >9.2 >9.2 
9 791 ±11 + (28) >2.72 >9.2 >9.2 >9.2 >9.2 >9.2 
RPMI 502±43        
DMSO 620±54        
Dexamethasonec 258 ±65        
Galanthamined   0.003      
Chloroquinee    0.0096 0.089± 0.01      
Cycloguanile    0.0095 0.81 ± 0.19    
Pyrimethaminee    0.0200 7.7 ± 2.14    
PB113f      0.064   
Ellipticineg       0.093  
Doxorubicing        0.56 
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MeOH extract 5.5 1250 − − − − 6 1250 − − 5 1250 5.3 500 − − 
Hexane extract 6 2500 6 2500 6 2500 5.5 1250 − − 6 2500 6.5 500 − − 
CH2Cl2  extract 5 1250 6 2500 5.5 1250 6 1250 5.8 625 6 1250 6.3 500 − − 
CHCl3 extract 7 625 7 1250 7 1250 7 1250 7 625 7 625 6.5 500 5.5 313 
1 7.5 250 8 250 5.5 250 7 250 − − − − 5.3 125 Nt Nt 
2 Nt Nt 4.5 500 4.5 500 6 250 5 250 Nt Nt 5 125 Nt Nt 
4 Nt Nt 5.5 250 5 500 6 250 5 250 Nt Nt 5 125 Nt Nt 
5 Nt Nt 5.5 250 4.5 250 6 250 5 125 Nt Nt 6 125 Nt Nt 
7 Nt Nt 4.5 500 4.5 250 5 250 5 250 Nt Nt 5 125 Nt Nt 
9 Nt Nt 6 500 4.5 250 5 250 5 250 Nt Nt 5 125 Nt Nt 
Amoxicillina 6 7.8 31 < 1   9 8 10 63 20 16 7 16   
Vancomycina     15 4           
Amphotericin Bb               18 <1 
  a Standard drug as a positive control for antibacterial testing.b Standard drug as a positive control for antifungal testing. 
   Nt: Not tested, −: Not active. 
 
Thus, our study verified an ethnopharmacological uses of C. crispa 
and strongly suggested that this plant can be a source of broad 
spectrum, biologically active natural products. Unlike the crude 
chloroform extract of this plant, none of the six pure alkaloids tested 
here exhibited anti-Trypanosoma brucei rhodesiense and 
cytotoxicity activities. The anti-acetylcholinesterase activity of 
compounds 2, 4 and 7, and the antiplasmodial activity of compound 
5 are reported here for the first time. Since compounds 1 and 5 
exhibited significant antiplasmodial, moderate acetylcholinesterase 
inhibition and mild level antimicrobial activities, it may be deduced 
that these two alkaloids (in alone or synergistically) may be 
responsible for the major activity of this plant. It is also possible 
that other minor alkaloids which were isolated here (but not tested) 
and the non-alkaloid components which we could not readily isolate 
may be responsible for the broad range of interesting biological 
activities of the crude extract of a plant.  
 
In summary, our study found the following: a) protopine (1) (950 
mg/2 kg dry weight) was the major alkaloid of C. crispa, b) 
complete NMR data for compounds 2 and 3 were lacking which we 
furnished here for the first time, c) compound 5 showed significant 
in vitro antiplasmodial activity without cytotoxicity and was 
identified as a potential scaffold that could generate more leads with 
enhanced antiplasmodial activity, and d) the in vitro biological 
activities were in alignment with the ethnopharmacological uses of 
this plant and thus substantiate its use in BTM, either individually 
or in combination with other medicinal ingredients, to treat a broad 




General: A rotary evaporator was used for solvent evaporation 
under reduced pressure at 35 °C-50 °C. Flash column 
chromatography packed with Merck Kieselgel 60 PF254 was used 
for separation and purification of alkaloids. Aluminium-backed 
silica plates (0.2 mm silica thickness, Merck) were used for 
separating isolates of smaller quantities. UV light (short wavelength 
of 254 nm, long wavelength of 366 nm) and Dragendorff’s reagent 
were used for visualization and detection of the separated alkaloid-
rich bands on TLC plates. Micromass Waters Platform LCZ (single 
quadrupole, MeOH as solvent) was used for obtaining the LR-ESI-
MS. Shimadzu GCMS-QP-5050 was used for recording the LR-EI-
MS by the direct insertion technique (at 70 eV). Micromass Waters 
Q-ToF Ultima (quadrupole time-of-flight) mass spectrometer was 
used for acquiring HR-ESI-MS. A 500 MHz Varian Unity Inova, 
500 MHz Varian Premium Shield (VNMRS PS 54), and 300 MHz 
Varian Mercury spectrometer were used for obtaining the NMR 
spectra (1H-NMR, gCOSY, 13C-NMR, APT, gHMBC, gHSQC, and 
gNOESY) using deuterated solvents (CD3OD or CDCl3) depending 
upon the solubility of compounds. IR spectra were obtained using a 
Smart Omni-Sampler Avator ESP Nicolet spectrometer. Reichert 
hot-stage apparatus was used for determining the melting point of 
the compounds. A JASCO 2000 Series polarimeter was used for 
measuring the optical rotations of the compounds using a sodium 
lamp and averages of ten optical readings were taken to obtain the 
observed rotation value. 
 
Plant material: C. crispa Prain, is a perennial yellow flowering herb 
that grows to about 10-23 cm tall arising from stout woody 
rootstock [36-37]. The whole part of wild C. crispa was collected 
from Thuphu (Altitude: 3962 m; Latitude: 27° 51' 15.4''; Longitude: 
89° 27' 12.8''; global positioning system (GPS) point number: 187; 
Site number: P187; Slope: 40°; Aspect: South-East), under Lingshi 
block in Bhutan in August 2009. The collected plant material was 
air-dried and a herbarium specimen with voucher number 78 was 
deposited at the herbarium of the PRU, Thimphu, Bhutan. 
 
Extraction and isolation: The air-dried plant material (2 kg) was 
chopped into small pieces and was repeatedly extracted with 
methanol (AR/HPLC grade, 5 × 3 L over 48 h). The extract was 
filtered and then concentrated using a rotary evaporator to afford the 
crude methanol extract (58.22 g). The MeOH extract (10 g) was 
acidified with 5% HCl and then subjected to sequential 
fractionation and extraction using hexane (5 × 60 mL) and CH2Cl2 
(5 × 60 mL). Two fractionated extracts were concentrated resulting 
into hexane extract (1.34 g) and the CH2Cl2 extract (2.90 g). The 
remaining acidified aqueous solution was basified (pH 9-11) with 
NH4OH solution, then extracted with CHCl3 (5  60 mL). The 
CHCl3 extract was washed (H2O), dried (Na2SO4) and the solvent 
was evaporated under reduced pressure to yield a crude alkaloid-
rich CHCl3 extract (80 mg). Dragendorff’s reagent was prepared 
[38] for staining the TLC plate loaded with alkaloid. A small 
portion of each of these crude extracts (40 mg each) was used for 
biological activity studies. Each extract obtained above was then 
subjected to fractional crystallization (mostly methanol/chloroform) 
followed by repeated separation and purification processes using 
column chromatography on silica gel (mobile phase: gradient eluant 
of increasing solvent polarities mainly using MeOH (1-30%) and 
CHCl3) until pure alkaloids were obtained. Fractions of smaller 
quantities and those compounds with closer Rf values were 
separated repeatedly using Preparative Thin Layer 
Chromatography. Finally, nine known isoquinoline alkaloids 1–9 




17.6 mg (0.00088 % dry weight), white amorphous solid.  
MP: 226-228 °C. 
[α]D: inactive.  
1H-NMR and 13C-NMR: see Table 1. 
LR-ESI-MS (m/z): 368 [M+H+]. 
LR-EI-MS (m/z): 367 [M+•], 295, 279, 257, 237, 209, 190, 162 
(100%), 149, and 134. 






4.5 mg (0.000225% dry weight), pale green solid. 
MP: 180-183 °C. 
[α]D: inactive. 
IR (KBr): νmax 792, 939, 1042, 1239, 1365, 1454, 1484, 1656 cm-1.  
1H-NMR and 13C-NMR see Table 1. 
LR-ESI-MS (m/z): 384 [M+H+]. 
LR-EI-MS (m/z): 383 [M+•], 340, 312, 297, 277, 253, 220, 204, 190, 
162 (100%), 149 and 134. 




Anti-inflammatory assay: The methanol, hexane, dichloromethane 
and chloroform extracts of C. crispa were prepared using the 
method described by Wangchuk et al., [7]. Cell culture and in vitro 
bioassays were performed as previously described [39]. Cells were 
incubated with crude plant extracts and pure compounds of C. 
crispa alone or in combination with purified LPS (100 ng/mL) from 
Escherichia coli serotype O127 : B8 (Sigma, USA) for 3.5 hr. 
Supernatants were collected from individual wells by centrifugation 
and assayed for TNF. The cell viability or the cytotoxic effects of 
crude extracts and pure compounds in THP-1 cells were determined 
by the Trypan-blue (Gibco-Invitrogen, USA) stain exclusion assay. 
Cells were incubated with varying concentration of crude extracts 
as 0, 25, 50, 100 and 200 µg/mL and that of pure compounds as 0, 
1.95, 3.9, 7.8, 15.6 and 31.25 µg/mL. The concentration that 
showed the highest cell viability (without significant cell reduction) 
was chosen as the final concentration for crude extracts (50 µg/mL) 
and pure compounds (3.9 µg/mL). Cell suspension was mixed with 
Trypan Blue which stained dead cells. The viable and dead cells 
were counted with a hemacytometer under an inverted microscope. 
Cell viability was determined from the ratio of viable cells over 
total cells. Results were expressed as means with standard 
deviations (± SD). The percentage of cell viability was calculated 
by the formula:  
  
% Cell viability = 100 × (1−(dead cells/total cells). 
 
TNF-α production in THP-1 cell culture supernatants were 
measured using cytokine-specific sandwich quantitative enzyme-
linked immunosorbent assays (ELISAs) according to the 
manufacturer’s instructions (R & D Systems, USA). The 96-well 
microtiter plates (Corning, USA) were coated overnight with mouse 
anti-human TNF-α antibody as capture antibodies. The plates were 
washed with PBST (0.05% Tween 20) to remove excess capture 
antibody. To reduce non-specific binding, wells were blocked for 2 
h with bovine serum album (BSA) (1% (w/v) of BSA; Sigma, 
USA)) and washed with PBST. Recombinant human TNF-α was 
used as standard at the concentration of 15.6, 31.5, 62.5, 125, 250, 
500, and 1000 pg/mL. The standard or samples were added to 
appropriate wells and plates were incubated overnight. After 
washing, biotinylated goat anti-human TNF-α antibodies were 
added as detection antibodies and the mixture was incubated for 2 h. 
The plates were washed with PBST and incubated for 20 min with 
streptavidin-horseradish peroxidase conjugate. The 
tetramethylbenzidine (TMB) substrate was added to the plates as a 
color indicator and was incubated for 20 min. H2SO4 was added to 
stop the reaction. Absorbance was measured at 450 nm using a 
BioTek® Synergy™ HT (Multi-Detection Microplate Reader, USA). 
Cytokine concentration in each well was quantified from a standard 
curve and expressed as pg/mL of culture medium.  
 
The commercial anti-inflammatory drug, dexamethasone (10 
µg/mL), (Atlantic LabsComp. Ltd., Thailand) was used as a positive 
control. The experiments were performed three times in triplicate 
(3×3). Results were expressed as means with standard deviations (± 
SD). The percentage of TNF-α inhibition was calculated by the 
formula: 
 
% TNF-α inhibition =   100 × ((observed/baseline) − 1). 
 
Where observed = secreted TNF-α of experiment (pg/mL) and baseline = 
secreted TNF-α of DMSO (pg/mL). 
 
Statistical significance or differences were evaluated by GraphPad 
Prism version 5.01 using Student’s t-test with one-tailed 
distribution. A p-value ≤ 0.05 was considered statistically 
significant.  
 
Acetylcolinesterase inhibitory assay method: A rapid TLC 
bioautographic method described by Marston et al. [40] was used 
for acetylcholinesterase inhibitory testing. Galanthamine, which is a 
frontline AChE inhibitor used to treat Alzheimer’s disease, was 
used here as a reference compound. The tests were performed in 
triplicate. 
 
Other bioassay methods: The antimicrobial, antiplasmodial, anti-
Trypanosoma brucei rhodesiense and cytotoxicity assays were 
carried out using the methods, test strains and references/standard 
drugs as described by Wangchuk et al. [7].   
 
Acknowledgements – Financial support has been provided by the 
government of Australia in a form of an Endeavour Postgraduate 
Award to PW. Plant materials have been obtained from the 
Pharmaceutical and Research Unit, Ministry of Health, Thimphu, 
Bhutan. SK is an international Research Scholar of Howard Hughes 




[1] Majak W, Bai Y, Benn MH. (2003) Phenolic amides and isoquinoline alkaloids from Corydalis sempervirens. Biochemical Systematics and 
Ecology, 31, 649−651. 
[2] Schmeller T, Latz-Bruning B, Wink M. (1997) Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against 
microorganisms and herbivores. Phytochemistry, 44, 257−266.  
[3] Ma ZZ, Xu W, Jensen NH, Roth BL, Liu-Chen LY, Lee DYW. (2008) Isoquinoline alkaloids isolated from Corydalis yanhusuo and their binding 
affinities at the Dopamine D1 receptor. Molecules, 13, 2303−2312. 
[4] Li HL, Zhang WD, Liu RH, Zhang C, Han T, Wang XW, Wang XL, Zhu JB, Chen CL. (2006) Simultaneous determination of four active alkaloids 
from a traditional Chinese medicine Corydalis saxicola Bunting. (Yanhuanglian) in plasma and urine samples by LC-MS-MS. Journal of 
Chromatography B, 831, 140−146. 
[5] Southon IW, Buckingham J. (1989) Dictionary of Alkaloids. Chapman and Hall, London. 
[6] Tenzin S. (2007) Traditional Medicine Formulary of Bhutan. Institute of Traditional Medicine Services, Ministry of Health, Thimphu, Bhutan. 
[7] Wangchuk P, Keller PA, Pyne SG, Taweechotipatr M, Tonsomboon A, Rattanajak R, Kamchonwongpaisan S. (2011) Evaluation of an 
ethnopharmacologically selected Bhutanese medicinal plants for their major classes of phytochemicals and biological activities. Journal of 
Ethnopharmacology, 137, 730−742. 
6   
[8] Manske RHF, Rodrigo R, MacLean DB, Gracey DEF, Saunders JK. (1969a) Structure of sibiricine, an alkaloid of Corydalis sibirica. Canadian 
Journal of Chemistry, 47, 3585−3588. 
[9] Taylor and Francis Group, 2011. Dictionary of natural products. CHEMnetBase, Chemical Database Online, DNP 19.2. Available at: 
http://www.chemnetbase.com. ezproxy.uow.edu.au/.  
[10] Forgacs P, Provost J. (1985) Presence of rhoeagenine in Fumaria parviflora. Journal of Natural Products, 48, 1000−1001. 
[11] Shamma M, Moniot JL. (1977) Isoquinoline Alkaloids Research, Plenum Press, New York and London, 337−353.  
[12] Guinaudeau H, Shamma M. (1982) The protopine alkaloids. Journal of Natural Products, 45, 237−246. 
[13] Hanus V, Dolejs L, Mueller B, Doepke W. (1967) Mass spectra of 13-Oxoprotopine alkaloids and their tetrahydro derivatives. Collection of 
Czechoslovak Chemical Communications, 32, 1759−1766.  
[14] Brochmann-Hanssen E, Leung AY, Ilirai K, Zanati G. (1970) Opium alkaloids VIII; Isolation of salutaridine and 13-oxycryptopine. Planta Medica, 
18, 366−371. 
[15] Wangchuk P, Bremner JB, Samten, Rattanajak R, Kamchongpaisan S. (2010) Anti-plasmodial agents from the Bhutanese medicinal plant Corydalis 
calliantha. Phytotherapy Research, 24, 481−485. 
[16] Seger C, Sturm S, Strasser EM, Ellmerer E, Stuppner H. (2004) 1H and 13C NMR signal assignment of benzylisoquinoline alkaloids from Fumaria 
officinalis L. (Papaveraceae). Magnetic Resonance in Chemistry, 42, 882−886. 
[17] Takahashi H, Iguchi M, Onda M. (1985) Utilization of protopine and related alkaloids. XVII. Spectroscopic studies on the ten-membered ring 
conformations of protopine and α-Allocryptopine. Chemistry and Pharmaceutical Bulletin, 33, 4775−4782. 
[18] Lee J, Shon MY, Jang DS,  Ha TJ, Hwang SW, Nam SH, Seo EK, Park KH, Yang MS. (2005) Cytotoxic isoquinoline alkaloids from Chelidonium 
majus var. asiaticum. Agricultural Chemistry and Biotechnology, 48, 198-201. 
[19] Chrzanowska M. (1995) Synthesis of isoquinoline alkaloids. Total synthesis of (±)-stylopine. Journal of Natural Products, 58, 401−407. 
[20] Narasimhan NS, Mali RS, Kulkarni BK. (1983) Synthetic application of lithiation reactions-XVI. Synthesis of stylopine and sinactine. Tetrahedron, 
39, 1975−1982. 
[21] Costa EV, Marques FA, Pinheiro MLB, Vaz NP, Duarte MCT, Delarmelina C, Braga RM, Maia BHLNS. (2009) 7,7-Dimethylaporphine alkaloids 
from the stem of Gautteriopsis friesiana. Journal of Natural Products, 72, 1516−1519. 
[22] Shah GN, Zaman A, Khan MA, Gray AI, Provan GJ, Waterman PG. (1989) (±)-Severzinine from Corydalis flabellata: Interpretation of NMR 
spectra. Journal of Natural Products, 52, 1027−1031.  
[23] Preisner RM, Shamma M. (1980) The spirobenzylisoquinoline alkaloids. Journal of Natural Products, 43, 305−318. 
[24 Margvelashvili NN, Tolkachev ON, Prisyazhnyuk NP, Kiryanova AT. (1978) A comparative study of the alkaloids of Corydalis species. Khimiya 
Prirodnykh Soedinenii, 5, 592−594. 
[25] Manske RHF, Rodrigo RGA, MacLean DB, Gracey DEF, Saunders JK. (1969b) The structure of ochrobirine. Canadian Journal of Chemistry, 47, 
3589−92. 
[26] Basha SA, Mishra RK, Jha RN, Pandey VB, Singh UP. (2002) Effect of berberine and (±)-bicuculline isolated from Corydalis chaerophylla on 
spore germination of some fungi. Folia Microbiologica, 47, 161−165. 
[27] Edwards OE, Handa KL. (1961) The alkaloids of Corydalis govaniana. Canadian Journal of Chemistry, 39, 1801−1804. 
[28] Delgado AV, McManus AT, Chambers JP. (2003) Production of tumor necrosis factor-α, interleukin 1-beta, interleukin 2, and interleukin 6 by rat 
leukocyte subpopulations after exposure to substance P. Neuropeptides, 37, 355–361. 
[29] Vacek J, Walterova D, Vrublova E, Simanek V. (2010) The chemical and biological properties of protopine and allocryptopine. Heterocycles, 81, 
1773−1789. 
[30] Orhana I, Ozcelik B, Karaoglu T, Sener B. (2007) Antiviral and antimicrobial profiles of selected isoquinoline alkaloids from Fumaria and 
Corydalis species. Zeitschrift für Naturforschung C, 62, 19−26. 
[31] Mahady GB, Pendland SL, Stoia A, Chadwick LR. (2003) In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria 
canadensis and Hydrastis canadensis. Phytotherapy Research, 17, 217−221. 
[32] Saeed SA, Gilani AH, Majoo RU, Shah BH. (1997) Anti-thrombotic and anti-inflammatory activities of protopine. Pharmacological Research, 36, 
1−7. 
[33] Kaya GI, Sarıkaya B, Onur MA, Somer NU, Viladomat F, Codina C, Bastida J, Lauinger IL, Kaiser M, Tasdemir D. (2011) Antiprotozoal alkaloids 
from Galanthus trojanus. Phytochemistry Letters, 4, 301–305. 
[34] Cunha EVLD, Fechine IM, Guedes DN, Filho JMB, Silva MSD. (2005) Protoberberine alkaloids. In The Alkaloids. Vol. 62, Cordell GA (Ed). 
Amsterdam, 1−75. 
[35] Dreyfuss G, Allais DP, Guinaudeau H, Bruneton J. (1987) Antimalarial activity of isoquinoline alkaloids in mouse. Annales Pharmaceutiques 
Françaises, 45, 361−366. 
[36] Grierson AJC, Long DG. (1984) Flora of Bhutan: Including a Record of Plants from Sikkim. Vol. 1, Part 2, Royal Botanic Garden, Edinburgh, 395. 
[37] Anonymous. (2008) Guidelines for Identification and Collection of Medicinal Plants in Bhutan. Department of Agriculture, Ministry of 
Agriculture, Thimphu, Bhutan, 25−28.  
[38] Svendsen AB, Verpoorte R. (1983) Chromatography of alkaloids. In Journal of Chromatography Library, 502. 
[39] Taweechotipatr M, Iyer C, Spinler JK, Versalovic J, Tumwasorn S. (2009) Lactobacillus saerimneri and Lactobacillus ruminis: novel human-
derived probiotic strains with immunomodulatory activities. FEMS Microbiology Letters, 293, 65−72. 
[40] Marston A, Kissling J, Hostettmann K. (2002) A rapid TLC bioautographic method for the detection of acetylcholinesterase and 
butyrylcholinesterase inhibitors in plants. Phytochemical Analysis, 13, 51–54.  
 
